UK-based medical equipment maker CMR Surgical has unveiled a next-generation surgical robotic system, called Versius, to provide a portable option for minimal access surgery.
The robotic system is designed to address the complexities and offer improved access during minimal access surgeries.
Versius comes with a small form and individually cart-mounted arms, which enable its transportability between operating rooms and hospitals. The portability is said to also allow easy setup and patient access.
According to CMR Surgical, the new surgical robotic system bio-mimics the human arm and offers freedom of port placement with benefits of small fully-wristed instruments.
In addition, Versius features 3D HD vision, easy instrument control and various options for working positions.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
CMR Surgical CEO Martin Frost said: “We believe Versius represents a paradigm shift in surgery. The ground-breaking design, coupled with genuine affordability, means that patients everywhere have the potential to benefit from the advantages of minimal access surgery.”
Founded in 2014, the company primarily focuses on developing robotic systems to make minimal access surgery accessible and affordable.
According to Accuray Research, the current $4bn global annual revenues of robot-assisted minimal access surgery market are estimated to reach $20bn by 2025.
In June this year, CMR Surgical raised $100m in a series B financing round. The company said that the funds would be used to support the preparation of Versius for commercialisation.
Currently, the company is working on validation studies required for regulatory approval in Europe. The Versius system is expected to be launched for use in the UK and continental Europe hospitals next year.
CMR Surgical is also planning for an international expansion.